位置:首页 > 蛋白库 > BORG1_HUMAN
BORG1_HUMAN
ID   BORG1_HUMAN             Reviewed;         210 AA.
AC   O14613; B2RD85; Q9UNS0;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   03-AUG-2022, entry version 157.
DE   RecName: Full=Cdc42 effector protein 2;
DE   AltName: Full=Binder of Rho GTPases 1;
GN   Name=CDC42EP2; Synonyms=BORG1, CEP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9253601; DOI=10.1101/gr.7.7.725;
RA   Guru S.C., Agarwal S.K., Manickam P., Olufemi S.-E., Crabtree J.S.,
RA   Weisemann J.M., Kester M.B., Kim Y.S., Wang Y., Emmert-Buck M.R.,
RA   Liotta L.A., Spiegel A.M., Boguski M.S., Roe B.A., Collins F.S.,
RA   Burns A.L., Marx S.J., Chandrasekharappa S.C.;
RT   "A transcript map for the 2.8-Mb region containing the multiple endocrine
RT   neoplasia type 1 locus.";
RL   Genome Res. 7:725-735(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH RHOQ AND CDC42, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Embryo;
RX   PubMed=10490598; DOI=10.1128/mcb.19.10.6585;
RA   Joberty G., Perlungher R.R., Macara I.G.;
RT   "The Borgs, a new family of Cdc42 and TC10 GTPase-interacting proteins.";
RL   Mol. Cell. Biol. 19:6585-6597(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CDC42, MUTAGENESIS
RP   OF 39-HIS--HIS-42, AND SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=11035016; DOI=10.1074/jbc.m007039200;
RA   Hirsch D.S., Pirone D.M., Burbelo P.D.;
RT   "A new family of Cdc42 effector proteins, CEPs, function in fibroblast and
RT   epithelial cell shape changes.";
RL   J. Biol. Chem. 276:875-883(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-176 AND PHE-191.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SEPT7.
RX   PubMed=11584266; DOI=10.1038/ncb1001-861;
RA   Joberty G., Perlungher R.R., Sheffield P.J., Kinoshita M., Noda M.,
RA   Haystead T., Macara I.G.;
RT   "Borg proteins control septin organization and are negatively regulated by
RT   Cdc42.";
RL   Nat. Cell Biol. 3:861-866(2001).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31 AND SER-141, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Probably involved in the organization of the actin
CC       cytoskeleton. May act downstream of CDC42 to induce actin filament
CC       assembly leading to cell shape changes. Induces pseudopodia formation
CC       in fibroblasts in a CDC42-dependent manner.
CC       {ECO:0000269|PubMed:10490598, ECO:0000269|PubMed:11035016}.
CC   -!- SUBUNIT: Interacts with RHOQ and CDC42 in a GTP-dependent manner, and
CC       with SEPT7. {ECO:0000269|PubMed:10490598, ECO:0000269|PubMed:11035016,
CC       ECO:0000269|PubMed:11584266}.
CC   -!- INTERACTION:
CC       O14613; Q9UNA1: ARHGAP26; NbExp=3; IntAct=EBI-3438291, EBI-1390913;
CC       O14613; Q9UNA1-2: ARHGAP26; NbExp=3; IntAct=EBI-3438291, EBI-16430964;
CC       O14613; Q9NQ75-2: CASS4; NbExp=4; IntAct=EBI-3438291, EBI-12270182;
CC       O14613; P60953: CDC42; NbExp=10; IntAct=EBI-3438291, EBI-81752;
CC       O14613; P10606: COX5B; NbExp=3; IntAct=EBI-3438291, EBI-1053725;
CC       O14613; Q14511-2: NEDD9; NbExp=3; IntAct=EBI-3438291, EBI-11746523;
CC       O14613; Q9Y5B8: NME7; NbExp=6; IntAct=EBI-3438291, EBI-744782;
CC       O14613; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-3438291, EBI-79165;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system
CC       {ECO:0000269|PubMed:11035016}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:11035016}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:11035016}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the heart. Weakly expressed in
CC       the pancreas and liver. {ECO:0000269|PubMed:10490598}.
CC   -!- DOMAIN: The CRIB domain mediates interaction with CDC42.
CC   -!- SIMILARITY: Belongs to the BORG/CEP family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc42ep2/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF001436; AAB81206.1; -; mRNA.
DR   EMBL; AF163840; AAD48784.1; -; mRNA.
DR   EMBL; AF098290; AAD16185.1; -; mRNA.
DR   EMBL; AK315444; BAG37832.1; -; mRNA.
DR   EMBL; BT020004; AAV38807.1; -; mRNA.
DR   EMBL; AF548903; AAN39381.1; -; Genomic_DNA.
DR   EMBL; BC022337; AAH22337.1; -; mRNA.
DR   EMBL; BC075834; AAH75834.1; -; mRNA.
DR   CCDS; CCDS8099.1; -.
DR   RefSeq; NP_006770.1; NM_006779.3.
DR   RefSeq; XP_016872583.1; XM_017017094.1.
DR   AlphaFoldDB; O14613; -.
DR   BioGRID; 115702; 13.
DR   IntAct; O14613; 8.
DR   STRING; 9606.ENSP00000279249; -.
DR   iPTMnet; O14613; -.
DR   PhosphoSitePlus; O14613; -.
DR   BioMuta; CDC42EP2; -.
DR   EPD; O14613; -.
DR   jPOST; O14613; -.
DR   MassIVE; O14613; -.
DR   MaxQB; O14613; -.
DR   PaxDb; O14613; -.
DR   PeptideAtlas; O14613; -.
DR   PRIDE; O14613; -.
DR   ProteomicsDB; 48116; -.
DR   Antibodypedia; 29752; 223 antibodies from 30 providers.
DR   DNASU; 10435; -.
DR   Ensembl; ENST00000279249.3; ENSP00000279249.2; ENSG00000149798.5.
DR   Ensembl; ENST00000533419.1; ENSP00000431660.1; ENSG00000149798.5.
DR   GeneID; 10435; -.
DR   KEGG; hsa:10435; -.
DR   MANE-Select; ENST00000279249.3; ENSP00000279249.2; NM_006779.4; NP_006770.1.
DR   UCSC; uc001odl.3; human.
DR   CTD; 10435; -.
DR   DisGeNET; 10435; -.
DR   GeneCards; CDC42EP2; -.
DR   HGNC; HGNC:16263; CDC42EP2.
DR   HPA; ENSG00000149798; Low tissue specificity.
DR   MIM; 606132; gene.
DR   neXtProt; NX_O14613; -.
DR   OpenTargets; ENSG00000149798; -.
DR   PharmGKB; PA38396; -.
DR   VEuPathDB; HostDB:ENSG00000149798; -.
DR   eggNOG; ENOG502RY28; Eukaryota.
DR   GeneTree; ENSGT00940000161776; -.
DR   HOGENOM; CLU_073229_0_0_1; -.
DR   InParanoid; O14613; -.
DR   OMA; DQDLGHM; -.
DR   OrthoDB; 1244464at2759; -.
DR   PhylomeDB; O14613; -.
DR   TreeFam; TF331725; -.
DR   PathwayCommons; O14613; -.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013406; RHOQ GTPase cycle.
DR   SignaLink; O14613; -.
DR   SIGNOR; O14613; -.
DR   BioGRID-ORCS; 10435; 21 hits in 1077 CRISPR screens.
DR   ChiTaRS; CDC42EP2; human.
DR   GeneWiki; CDC42EP2; -.
DR   GenomeRNAi; 10435; -.
DR   Pharos; O14613; Tbio.
DR   PRO; PR:O14613; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; O14613; protein.
DR   Bgee; ENSG00000149798; Expressed in apex of heart and 93 other tissues.
DR   Genevisible; O14613; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; IMP:UniProtKB.
DR   GO; GO:0001515; F:opioid peptide activity; IEA:Ensembl.
DR   GO; GO:0031267; F:small GTPase binding; IPI:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0007015; P:actin filament organization; NAS:UniProtKB.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IDA:UniProtKB.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; TAS:UniProtKB.
DR   GO; GO:0031274; P:positive regulation of pseudopodium assembly; IDA:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IDA:UniProtKB.
DR   GO; GO:0007266; P:Rho protein signal transduction; IBA:GO_Central.
DR   InterPro; IPR029273; Cdc42_effect.
DR   InterPro; IPR017363; Cdc42_effector_prot_2.
DR   InterPro; IPR000095; CRIB_dom.
DR   Pfam; PF14957; BORG_CEP; 2.
DR   Pfam; PF00786; PBD; 1.
DR   PIRSF; PIRSF038036; Cdc42_effector_p2; 1.
DR   SMART; SM00285; PBD; 1.
DR   PROSITE; PS50108; CRIB; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell shape; Cytoplasm; Cytoskeleton; Membrane; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..210
FT                   /note="Cdc42 effector protein 2"
FT                   /id="PRO_0000212648"
FT   DOMAIN          30..44
FT                   /note="CRIB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00057"
FT   REGION          122..171
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        123..137
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        157..171
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976"
FT   MOD_RES         101
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5PQP4"
FT   MOD_RES         141
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:20068231"
FT   VARIANT         176
FT                   /note="N -> S (in dbSNP:rs4149839)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023001"
FT   VARIANT         191
FT                   /note="I -> F (in dbSNP:rs7120634)"
FT                   /evidence="ECO:0000269|Ref.6"
FT                   /id="VAR_023002"
FT   MUTAGEN         39..42
FT                   /note="HTIH->ATIA: No binding with CDC42; no induced
FT                   pseudopodia formation."
FT                   /evidence="ECO:0000269|PubMed:11035016"
FT   CONFLICT        92
FT                   /note="C -> V (in Ref. 3; AAD16185)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   210 AA;  22484 MW;  7755100672FFB69C CRC64;
     MSTKVPIYLK RGSRKGKKEK LRDLLSSDMI SPPLGDFRHT IHIGSGGGSD MFGDISFLQG
     KFHLLPGTMV EGPEEDGTFD LPFQFTRTAT VCGRELPDGP SPLLKNAISL PVIGGPQALT
     LPTAQAPPKP PRLHLETPQP SPQEGGSVDI WRIPETGSPN SGLTPESGAE EPFLSNASSL
     LSLHVDLGPS ILDDVLQIMD QDLDSMQIPT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024